AbbVie : ABBV

All AbbVie Articles

583 Articles

Jon C. Ogg | Apr 20, 2020 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, AEP, ANGI, Disney, DuPont, Gilead, Microsoft, Peloton, Shopify, Trivago and More

Monday's top analyst upgrades and downgrades included AbbVie, American Electric Power, ANGI Homeservices, DuPont, GileadSciences, Microsoft, Peloton Interactive, Shopify, Trivago…

Chris Lange | Apr 13, 2020 at 9:58 AM EDT

Big Pharma Short Sellers Focus on a Couple of Favorites

The March 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Douglas A. McIntyre | Mar 31, 2020 at 12:29 PM EDT

Co-Diagnostics Stock Is Not a Penny Stock Anymore

Co-Diagnostics is on many shortlists of companies with partial medical solutions to slow the coronavirus outbreak. Investors have been on…

Jon C. Ogg | Mar 23, 2020 at 9:16 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, AES, AT&T, Boeing, Carnival, CME, Coca-Cola, Comcast, Honeywell, Lululemon, Netflix, Shopify, Starbucks, Twitter and More

Monday's top analyst calls included AbbVie, AES, AT&T, Boeing, Carnival, CME, Coca-Cola, Comcast, Honeywell, Lululemon Athletica, Netflix, Shopify, Starbucks and…

Chris Lange | Mar 11, 2020 at 9:44 AM EDT

Short Sellers Run for Cover From Big Pharma Stocks

The February 28 short interest data have been compared with the previous figures, and short interest in these top pharmaceutical…

Jon C. Ogg | Feb 27, 2020 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Cree, Etsy, Gilead, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems, Virgin Galactic and More

Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Cree, Etsy, Gilead Sciences, Pfizer, Rite Aid, Solar Edge, Square,…

Chris Lange | Feb 27, 2020 at 8:45 AM EST

Big Pharma Scares Off Short Sellers

The February 14 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Feb 20, 2020 at 7:35 AM EST

15 Top ESG Stocks That Look Undervalued for 2020

With billions of dollars flowing in, it has become impossible to ignore the ESG trend. These 15 top ESG stocks…

Lee Jackson | Feb 19, 2020 at 7:10 AM EST

The 5 Highest-Yielding Dividend Aristocrat Stocks Have Solid Total Return Potential

With even moderate appreciation in the share prices of these top companies, investors should be looking at double-digit total return…

Jon C. Ogg | Feb 18, 2020 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Arconic, CenturyLink, eHealth, Nvidia, Salesforce, Tesla, Teva and More

Tuesday's top analyst upgrades, downgrades and initiations included AbbVie, Apple, Arconic, CenturyLink, eHealth, Nvidia, Salesforce.com, Tesla and Teva Pharmaceutical.

Chris Lange | Feb 12, 2020 at 9:50 AM EST

Big Pharma Sees a Rising Tide in Short Interest

The January 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Feb 10, 2020 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Arch Coal, FedEx, Ford, GM, Nvidia, Skyworks, Stitch Fix, WWE and More

Monday's top analyst upgrades, downgrades and initiations included AbbVie, Apple, Arch Coal, FedEx, Ford, General Motors, Nvidia, Skyworks Solutions, Stitch…

Chris Lange | Feb 7, 2020 at 10:20 AM EST

AbbVie Wows Again With Q4 Results

AbbVie released better than expected fourth-quarter financial results before the markets opened on Friday.

Jon C. Ogg | Feb 6, 2020 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive,…

Chris Lange | Jan 28, 2020 at 9:35 AM EST

Short Sellers Can’t Make Up Their Mind on Big Pharma

The January 15 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 13 14 15 16 17 … 39

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, AEP, ANGI, Disney, DuPont, Gilead, Microsoft, Peloton, Shopify, Trivago and More

Big Pharma Short Sellers Focus on a Couple of Favorites

Co-Diagnostics Stock Is Not a Penny Stock Anymore

Top Analyst Upgrades and Downgrades: AbbVie, AES, AT&T, Boeing, Carnival, CME, Coca-Cola, Comcast, Honeywell, Lululemon, Netflix, Shopify, Starbucks, Twitter and More

Short Sellers Run for Cover From Big Pharma Stocks

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Cree, Etsy, Gilead, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems, Virgin Galactic and More

Big Pharma Scares Off Short Sellers

15 Top ESG Stocks That Look Undervalued for 2020

The 5 Highest-Yielding Dividend Aristocrat Stocks Have Solid Total Return Potential

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Arconic, CenturyLink, eHealth, Nvidia, Salesforce, Tesla, Teva and More

Big Pharma Sees a Rising Tide in Short Interest

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Arch Coal, FedEx, Ford, GM, Nvidia, Skyworks, Stitch Fix, WWE and More

AbbVie Wows Again With Q4 Results

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Short Sellers Can’t Make Up Their Mind on Big Pharma

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, AEP, ANGI, Disney, DuPont, Gilead, Microsoft, Peloton, Shopify, Trivago and More

Big Pharma Short Sellers Focus on a Couple of Favorites

Co-Diagnostics Stock Is Not a Penny Stock Anymore

Top Analyst Upgrades and Downgrades: AbbVie, AES, AT&T, Boeing, Carnival, CME, Coca-Cola, Comcast, Honeywell, Lululemon, Netflix, Shopify, Starbucks, Twitter and More

Short Sellers Run for Cover From Big Pharma Stocks

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Cree, Etsy, Gilead, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems, Virgin Galactic and More

Big Pharma Scares Off Short Sellers

15 Top ESG Stocks That Look Undervalued for 2020

The 5 Highest-Yielding Dividend Aristocrat Stocks Have Solid Total Return Potential

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Arconic, CenturyLink, eHealth, Nvidia, Salesforce, Tesla, Teva and More

Big Pharma Sees a Rising Tide in Short Interest

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Arch Coal, FedEx, Ford, GM, Nvidia, Skyworks, Stitch Fix, WWE and More

AbbVie Wows Again With Q4 Results

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Short Sellers Can’t Make Up Their Mind on Big Pharma

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation